Advances in Brief Involvement of B Lymphocytes in the Growth Inhibition of Human Pulmonary Melanoma Metastases in Athymic flu / flu Mice by an Antibody-Lymphotoxin Fusion Protein 1

R. Reisfeld,Stephen D. Gilies,J. Mendelsohn,N. Varki,Rgen C. Jü Becker
Abstract:Antibody.cytokinefusionproteinscan target biologicallyactivecyto kinesto varioustumor sites,achievinglocalconcentrationsufficientto inducehost immuneresponsesleadingto tumor elimination.Here, we demonstratethe therapeuticefficacyof a tumor-specificantibody-lym. photoxinfusionprotein(ch225-LT)onxenograftedpulmonarymetastases of humanmelanoma. In vitrostudiesindicateda directcytotoxiceffectof suchconstructson melanomacellsvia the inductionof apoptosis,as demonstrated by cell cycle analysis and DNA fragmentation. However, ch225-LTlackedany therapeuticeffectin immunedeficientC.B17scid/ beige and scid/scid mice, indicating the insufficiency of this direct mech anism in vivo. In contrast, in athymic nu/nu mice, ch225-LT completely inhibited outgrowth of the xenografted tumor. This therapeutic effect was accompanied by infiltrations of CD4S+, Mac-1+, and aslalo-GM1+ cells into the tumor; B220+ cellswerepresentin the surroundingtissueand theperipheryof thetumor.The functionalroleof asialo-GM1+cellswas confirmed by in vivo depletion studies. Our data indicate that an antibody lymphotoxinfusionproteineffectivelyinhibitsthegrowthofdisseminated melanomametastasesby mechanismsthat functionin the absenceof matureT cells,but requireB, NK, and otherasialo-GM1+ cells.
What problem does this paper attempt to address?